Omvoh Injection, Solution
Product Images NDC 0002-8870

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Omvoh (NDC 0002-8870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Omvoh 100mg Ai 1)

Illustration of two Omvoh (mirikizumab-mrkz) subcutaneous injection pens with dose indicator windows and locking symbols. The pens have blue caps and transparent bases, showing the internal mechanism for dose delivery.*

FDA Label Image

Figure (Omvoh 100mg Ai 2)

Illustration of the Omvoh (mirikizumab-mrkz) prefilled injection pen showing labeled parts including a blue injection button at the top, lock ring with lock and unlock symbols on the body, medicine and needle visible near the clear base, a gray base cap at the bottom, and dosage indication combining 100 mg/mL plus 100 mg/mL to equal one full dose.*

FDA Label Image

Figure (Omvoh 100mg Ai 3)

An illustration showing a subcutaneous injection device labeled for Omvoh (mirikizumab-mrkz), a human prescription drug by Eli Lilly and Company. The image highlights a specific black rectangular section on the syringe barrel, potentially indicating a label or window feature related to the medication delivery.*

FDA Label Image

Figure (Omvoh 100mg Ai 4)

An instructional illustration showing a syringe with a blue cap containing Omvoh (mirikizumab-mrkz) injection, solution for subcutaneous use. The image highlights steps involving unlocking and locking mechanisms on the syringe, indicated by padlock icons, likely guiding proper preparation or administration technique.*

FDA Label Image

Figure (Omvoh 100mg Ai 5)

An instructional illustration showing a hand holding a prefilled syringe of Omvoh (mirikizumab-mrkz) injection, solution. The diagram highlights the gray base cap at the syringe end, with an arrow indicating the direction to twist and remove the cap before use, and identifies the needle on the syringe tip.*

FDA Label Image

Figure (Omvoh 100mg Ai 6)

An instructional illustration showing the use of a subcutaneous injection pen for Omvoh (mirikizumab-mrkz). The image highlights holding the injection pen and positioning it against the skin with a clear base, demonstrating how the medication is administered.*

FDA Label Image

Figure (Omvoh 100mg Ai 7)

An instructional illustration showing a person holding a syringe injection device aimed at the lower abdomen for subcutaneous injection. A red arrow points to the device tip, and a circle with "10 seconds" indicates the recommended injection time.*

FDA Label Image

Figure (Omvoh 100mg Ai 8)

Illustration of a component of the Omvoh injection device showing a clear plastic base and a labeled gray plunger, part of the subcutaneous injection mechanism.*

FDA Label Image

Figure (Omvoh 100mg Ai 9)

An instructional illustration showing a hand disposing of a used syringe labeled Omvoh into a red sharps disposal container. The syringe is a single-use subcutaneous injection device, consistent with the Omvoh (mirikizumab-mrkz) injection, solution form.*

FDA Label Image

Figure (Omvoh Ai Lock)

FDA Label Image

Figure (Omvoh Ai Unlock)

FDA Label Image

Package Label – Omvoh 100 mg Prefilled Pen (Omvoh Carton 100mg Pen 078 00)

Omvoh 100 mg/mL (mirikizumab-mrkz) injection, a subcutaneous solution, displayed on a carton label. The packaging shows two 1 mL single-dose prefilled pens and includes storage instructions, manufacturer Eli Lilly and Company, and usage notes specifying a 200 mg dose requires two pens administered sequentially.*

FDA Label Image

Package Label – Omvoh 300 mg Vial Carton (Omvoh Carton 300mg Vial 049 00)

Packaging label for Omvoh (mirikizumab-mrkz) injection, 300 mg/15 mL (20 mg/mL) solution for injection. The label indicates the product is manufactured by Eli Lilly and Company, includes storage instructions, dosage form as an intravenous infusion after dilution, and a barcode. The product is a single-dose vial, with instructions to keep refrigerated and protect from light.*

FDA Label Image

Figure (Omvoh Ifu Injection Sites)

Illustration showing recommended subcutaneous injection sites for Omvoh (mirikizumab-mrkz) injection solution. Highlighted areas for injection include the abdomen, thigh, and the back of the arm on a human figure from both front and back views.*

FDA Label Image

Figure (Qr V1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.